Skip to main content
Clinical Trials/NCT05302661
NCT05302661
Unknown
N/A

Effect of Re-education on Rebleeding Rate After Endoscopic Treatment of Esophageal and/or Gastric Varices in Patients With Liver Cirrhosis

Qilu Hospital of Shandong University1 site in 1 country508 target enrollmentFebruary 19, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Liver Cirrhosis
Sponsor
Qilu Hospital of Shandong University
Enrollment
508
Locations
1
Primary Endpoint
rebleeding
Last Updated
4 years ago

Overview

Brief Summary

A prospective, randomized controlled study on whether re-education after discharge can reduce the rebleeding rate after endoscopic treatment of esophageal and gastric varices in patients with liver cirrhosis

Detailed Description

After receiving esophageal variceal ligation and (or) gastric fundus variceal sclerotherapy, patients with outside hospitalthe rate of bleeding due to liver cirrhosis shall be re-educated outside the hospital, including diet, drugs, anticoagulation of portal vein thrombosis,regular endoscopic treatment, reexamination , nutrition, etc. The patients were divided into the first treatment group and the more thanonce treatment group according to whether they had received endoscopic treatment in the past

Registry
clinicaltrials.gov
Start Date
February 19, 2022
End Date
February 19, 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Esophageal and / or gastric varices ;
  • liver cirrhosis ;
  • patients receiving endoscopic treatment (esophagogastric variceal sclerosis and/or ligation) ;
  • All subjects or their guardians must sign the subject consent form before entering the test

Exclusion Criteria

  • Patients with mental illness, severe hearing loss and unable to take care of themselves ;
  • ASA score ≥ grade IV at discharge ;
  • Hepatic encephalopathy ≥ stage II;
  • Patients with liver cancer;
  • Pregnant and lactating women;
  • Patients who cannot sign informed consent

Outcomes

Primary Outcomes

rebleeding

Time Frame: 2 yeas

rebleeding from any channel can be followed up through medical institutions or telephone

Study Sites (1)

Loading locations...

Similar Trials